Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
129M
-
Number of holders
-
264
-
Total 13F shares, excl. options
-
93.5M
-
Shares change
-
+1M
-
Total reported value, excl. options
-
$2.58B
-
Value change
-
+$27.5M
-
Put/Call ratio
-
1.09
-
Number of buys
-
108
-
Number of sells
-
-122
-
Price
-
$27.61
Significant Holders of NEOGENOMICS INC - Common Stock, $0.01 par value (NEO) as of Q1 2020
290 filings reported holding NEO - NEOGENOMICS INC - Common Stock, $0.01 par value as of Q1 2020.
NEOGENOMICS INC - Common Stock, $0.01 par value (NEO) has 264 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 93.5M shares
of 129M outstanding shares and own 72.37% of the company stock.
Largest 10 shareholders include BlackRock Inc. (15.3M shares), VANGUARD GROUP INC (10.8M shares), Kopp Family Office, LLC (4.66M shares), Invesco Ltd. (3.86M shares), Artisan Partners Limited Partnership (3.31M shares), STATE STREET CORP (3.01M shares), JANUS HENDERSON GROUP PLC (2.79M shares), BROWN ADVISORY INC (2.7M shares), EAGLE ASSET MANAGEMENT INC (2.51M shares), and CARILLON TOWER ADVISERS, INC. (1.8M shares).
This table shows the top 264 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.